home > drugs a-z list > sucraid (sacrosidase oral solution) drug center > sucraid (sacrosidase oral solution) drug - side effects and drug interactions

Adverse experiences with Sucraid® (sacrosidase oral solution) in clinical trials were generally minor and were frequently associated with the underlying disease. In clinical studies of up to 54 months duration, physicians treated a total of 52 patients with Sucraid® (sacrosidase oral solution) . The adverse experiences and respective number of patients reporting each event (in parenthesis) were as follows: abdominal pain (4), vomiting (3), nausea (2), diarrhea (2), constipation (2), insomnia (1) headache (1) nervousness (1) and dehydration (1). Note: diarrhea and abdominal pain can be a part of the clinical presentation of the genetically determined sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID). One asthmatic child experienced a serious hypersensitivity reaction (wheezing) probably related to sacrosidase (see WARNINGS). The event resulted in withdrawal of the patient from the trial but resolved with no sequelae.

Neither drug-drug nor drug-food interactions are expected or have been reported with the use of Sucraid® (sacrosidase oral solution) . However, Sucraid® (sacrosidase oral solution) should not be reconstituted or consumed with fruit juice, since its acidity may reduce the enzyme activity.

Last reviewed on RxList: 2/13/2009
This monograph has been modified to include the generic and brand name in many instances.